A research study has found that a simple blood test may indicate whether post-menopausal hormone therapies present an elevated risk of a heart attack. The study, part of the Women`s Health Initiative (WHI), sponsored by the National Heart, Lung and Blood Institute of the National Institutes of Health, was conducted in 40 centers nationwide and included 271 cases of coronary heart disease in the first four years of the trials of estrogen alone and of estrogen plus progestin.
- Study finds it pays to be heart smart if considering hormone therapyThu, 22 May 2008, 8:21:57 EDT
- Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study findsThu, 6 May 2010, 12:50:59 EDT
- Blood cholesterol levels predict risk of heart disease due to hormone therapyFri, 23 May 2008, 14:35:54 EDT
- Estrogen therapy could be dangerous for women with existing heart riskTue, 25 Nov 2008, 14:43:39 EST
- WHI data confirm short-term heart disease risks of combination menopausal hormone therapyTue, 16 Feb 2010, 11:46:20 EST